| mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |
| mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
0.0043 |
0.9 |
| mRNA |
BRD-A02303741 |
CTRPv2 |
pan-cancer |
AAC |
-0.0028 |
0.9 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |
| mRNA |
YK 4-279 |
GDSC1000 |
pan-cancer |
AAC |
0.0026 |
0.9 |
| mRNA |
Cyclopamine |
GDSC1000 |
pan-cancer |
AAC |
-0.0037 |
0.9 |
| mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.0033 |
0.9 |
| mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
0.0025 |
0.9 |
| mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
-0.0023 |
1 |
| mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.0021 |
1 |